• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Italian Consensus Endorses Early Vasopressin for Specific Distributive Shock Phenotypes

by
November 16, 2026
in Health
Reading Time: 3 mins read
0
Italian Consensus Endorses Early Vasopressin for Specific Distributive Shock Phenotypes

Italian Consensus Endorses Early Vasopressin for Specific Distributive Shock Phenotypes

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

An Italian national consensus has established phenotype-driven, bedside-applicable guidance supporting the early adjunctive use of low-dose vasopressin in vasodilatory shock, identifying specific clinical scenarios where the non-adrenergic agent can restore vascular tone while limiting catecholamine exposure. Published in the Journal of Anesthesia, Analgesia and Critical Care, the consensus report provides practical recommendations aimed at achieving haemodynamic stabilisation, catecholamine sparing, and organ protection in critically ill and perioperative patients. To develop these recommendations, a multidisciplinary panel composed of intensivists and anaesthesiologists evaluated six complex clinical phenotypes using a formal consensus process to bridge existing gaps between clinical trial evidence and practical bedside decision-making.

Distributive shock represents a major cause of haemodynamic instability in both intensive care and perioperative environments, posing substantial management challenges for clinicians. Although norepinephrine remains the universally recommended primary treatment for restoring perfusion pressure, its administration is accompanied by dose-dependent adverse effects that include cardiac arrhythmias and myocardial ischaemia. Furthermore, the emergence of catecholamine resistance in severe shock states frequently diminishes its therapeutic efficacy. Growing clinical evidence suggests that vasopressin can effectively restore vascular tone through distinct non-adrenergic pathways, thereby reducing overall catecholamine exposure and potentially enhancing organ function, even as significant uncertainties have persisted regarding optimal intervention timing, precise patient selection, and practical implementation.

To resolve these implementation dilemmas, the multidisciplinary panel utilized a modified RAND/UCLA appropriateness method to evaluate the clinical suitability of vasopressin across diverse clinical presentations. The panel examined six distinct clinical phenotypes: overwhelming septic shock, septic shock accompanied by tachycardia or tachyarrhythmia, septic shock complicated by acute kidney injury, post-cardiac surgery refractory vasoplegia, persistent post-reperfusion shock during liver transplantation, and shock occurring in severe acute respiratory distress syndrome with right ventricular dysfunction. Each clinical scenario was explored through real-world composite vignettes designed to reflect authentic bedside challenges and enhance the practical relevance of the resulting consensus guidance.

Across the evaluated shock phenotypes, the panel rated early adjunctive low-dose vasopressin as an appropriate therapeutic intervention to support circulation. The consensus identified standard initiation thresholds, noting that vasopressin is frequently appropriate when baseline norepinephrine requirements reach approximately 0.2 micrograms per kilogram per minute. Moreover, in clinical situations where the risk of tachyarrhythmia is prominent, the experts rated the introduction of low-dose vasopressin as appropriate even earlier in the resuscitation trajectory, recommending consideration at norepinephrine doses between 0.1 and 0.2 micrograms per kilogram per minute to help mitigate adrenergic-driven heart rate acceleration and rhythm disturbances.

The consensus also focused on challenging perioperative scenarios, evaluating vasopressin therapy for post-cardiac surgery refractory vasoplegia and persistent post-reperfusion shock during liver transplantation procedures. In cases of refractory vasoplegia following cardiac surgery, the panel rated vasopressin as an appropriate agent to restore vascular tone and decrease catecholamine toxicity. However, the panel found that the strategy of tapering vasopressin prior to discontinuing norepinephrine remained uncertain due to disagreement among the participating clinicians, demonstrating that optimal cessation protocols represent an unresolved aspect of vasopressor management requiring further empirical investigation.

For patients presenting with shock in the context of severe acute respiratory distress syndrome and right ventricular dysfunction, the consensus rated vasopressin as appropriate first-line support. The panel emphasized that vasopressin possesses the distinct pharmacological property to maintain vascular tone without increasing pulmonary vascular resistance. This specific haemodynamic characteristic provides an essential clinical benefit in severe respiratory distress, allowing clinicians to support systemic blood pressure while avoiding adverse effects on pulmonary vascular resistance and preserving right ventricular function under critical conditions.

Synthesizing the broader clinical evidence base, the consensus noted that incorporating vasopressin into resuscitation strategies delivers meaningful catecholamine-sparing effects, reduces the risk of new-onset atrial fibrillation, and may lead to possible reductions in the need for renal replacement therapy. Nevertheless, the panel highlighted critical safety considerations and outlined major evidence gaps that continue to limit clinical decision-making. The consensus concluded by defining key priorities for future precision hemodynamic management research, specifically emphasizing the need to establish optimal clinical triggers, define phenotype-specific responses, and evaluate long-term patient outcomes across customized vasopressor strategies.

Subject of Research: Phenotype-driven vasopressin therapy in distributive shock

Article Title: Phenotype-driven use of vasopressin in distributive shock: results of a national consensus

Article References: Morselli, F., Coloretti, I., Monti, G., Panascia, E., Paternoster, G., Tritapepe, L., Ajello, V., Bignami, E., Cattaneo, S., Cecconi, M., Corona, A., De Pascale, G., Donadello, K., Donati, A., Forfori, F., Grasselli, G., Grasso, S., Guarracino, F., Panarello, G., … Girardis, M. (2026). Phenotype-driven use of vasopressin in distributive shock: results of a national consensus. Journal of Anesthesia, Analgesia and Critical Care. https://doi.org/10.1186/s44158-026-00472-x

Image Credits: AI Generated

DOI: 10.1186/s44158-026-00472-x

Keywords: vasopressin, distributive shock, vasodilatory shock, norepinephrine, catecholamine sparing, septic shock, tachyarrhythmia, acute kidney injury, vasoplegia, cardiac surgery, liver transplantation, acute respiratory distress syndrome, right ventricular dysfunction, pulmonary vascular resistance, RAND/UCLA appropriateness method, atrial fibrillation, renal replacement therapy

News Source: Ophelia Keating. (November 16, 2026). Italian Consensus Endorses Early Vasopressin for Specific Distributive Shock Phenotypes. Scienmag.

Tags: acute kidney injuryacute respiratory distress syndromeAtrial FibrillationCardiac Surgerycatecholamine sparingdistributive shockliver transplantationnorepinephrinepulmonary vascular resistanceRAND/UCLA appropriateness methodrenal replacement therapyright ventricular dysfunctionseptic shockTachyarrhythmiavasodilatory shockvasoplegiavasopressin
Share12Tweet7Share2ShareShareShare1

Related Posts

Next-Generation CAR-T Strategies Tackle Clinical Barriers in Advanced Breast Cancer

Next-Generation CAR-T Strategies Tackle Clinical Barriers in Advanced Breast Cancer

November 17, 2026
Trace Element Contamination Detected in Household Dust in Rural Northern Thailand

Trace Element Contamination Detected in Household Dust in Rural Northern Thailand

November 17, 2026

Fetal Inferior Vena Cava Reverse-Flow Fraction Declines Through Second Half of Pregnancy

November 17, 2026

Head-Down Tilt Positioning Reduces Parasagittal Meningeal Lymphatic Flow Velocity in Humans

November 17, 2026

POPULAR NEWS

  • Review Links Hyperinsulinaemia to Molecular Pathways in Cholesterol Gallstone Formation

    Review Links Hyperinsulinaemia to Molecular Pathways in Cholesterol Gallstone Formation

    29 shares
    Share 12 Tweet 7
  • Self-Assessed Hirsutism Accurately Flags Endocrine and Metabolic Disruptions in Oligomenorrheic Women

    29 shares
    Share 12 Tweet 7
  • Genomic Radiosensitivity Metrics Fail to Predict Survival in Canine Sinonasal Tumors

    29 shares
    Share 12 Tweet 7
  • Global Review Highlights Escalating Burden and Care Deficits for Migraine Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Entropy Framework Reveals Unintuitive Gene Specificity in Mouse and Human Cells

Next-Generation CAR-T Strategies Tackle Clinical Barriers in Advanced Breast Cancer

Trace Element Contamination Detected in Household Dust in Rural Northern Thailand

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.